Mostrar el registro sencillo del ítem

dc.contributor.authorParam, Juan C
dc.contributor.authorWilson, Christopher
dc.contributor.authorVelarde, Diego
dc.contributor.authorGiraldo, Jaime
dc.contributor.authorPoppiti, Robert J
dc.contributor.authorMesko, Thomas W
dc.date.accessioned2022-10-27T20:51:40Z
dc.date.available2022-10-27T20:51:40Z
dc.date.issued2003
dc.identifier.urihttps://hdl.handle.net/10946/7031
dc.description.abstractMucinous carcinoma of the breast (MCB) may be associated with a low risk of axillary metastases. To evaluate the incidence of axillary nodal metastasis in MCB, a review of all cases from January 1990 to July 2000 was performed. Pure MCB was defined as all tumor cells being completely surrounded by mucin. Patient demographics, tumor size, estrogen receptor status, total number of dissected lymph nodes, and incidence of nodal metastasis were studied. Deeper sections on the lymph nodes from the pure tumors were performed and stained with low-molecular cytokeratin. Because pure MCB seems unlikely to metastasize, axillary lymph node staging in these patients may not be necessary. The presence of lymph node metastases strongly indicates the presence of a mixed MCB.spa
dc.language.isoenspa
dc.relation.urihttps://pubmed.ncbi.nlm.nih.gov/11888873/
dc.subjectMucinous breast cancerspa
dc.subjectAxillary node stagingspa
dc.subjectAxillary node dissectionspa
dc.subjectBreast carcinomaspa
dc.titlePure mucinous carcinoma of the breast: Is axillary staging necessary?spa
dc.typeTrabajo de Gradospa
cesvirtual.contributor.authorhttps://pubmed.ncbi.nlm.nih.gov/11888873/
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccessspa
datacite.rightshttp://purl.org/coar/access_right/c_14cbspa


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem